The Valley Hospital Performs First Implant of Newly Approved Evoque Tricuspid Valve Replacement System
Paramus, NJ, April 30, 2025 – The Valley Hospital has successfully completed its first implant of the Evoque tricuspid valve replacement system, manufactured by Edwards Lifesciences, following its recent FDA approval.
The Evoque system is the first transcatheter therapy approved for the treatment of severe symptomatic tricuspid regurgitation (TR), a condition in which the valve between the two right heart chambers – the right ventricle and right atrium – do not close properly, allowing blood to flow backward into the right atrium of the heart. This debilitating condition can cause symptoms such as shortness of breath and fatigue, and, if untreated, may lead to more serious conditions such as atrial fibrillation, an irregular rapid heart rate; heart failure, a chronic condition where the heart does not pump properly; or even sudden cardiac death.
The implant was performed at The Valley Hospital by the structural heart team, utilizing a minimally invasive transfemoral approach – accessing the valve through the femoral artery. The Evoque system is designed to replace the native tricuspid valve, reducing or eliminating regurgitation and significantly improving patient symptoms.
“We’re excited to offer this novel treatment to our patients with tricuspid regurgitation,” said Rajiv Tayal, MD, Director of the Cardiac Catheterization Laboratory and Structural Heart Program at The Valley Hospital. “The Evoque system provides a new treatment option that can improve symptoms and quality of life for patients who previously had limited treatment options.”
The FDA’s approval of the Evoque system follows the successful results of the TRISCEND II pivotal trial, which demonstrated that the Evoque system significantly reduced or eliminated tricuspid regurgitation and improved patients' overall quality of life.
This implantation reflects Valley’s continued commitment to advancing cardiovascular care and bringing innovative therapies and technologies to its community.
To learn more about structural heart care at Valley, please visit ValleyHealth.com/StructuralHeart.
Photo Credit: Edwards Lifesciences
What's Related